Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Shares Outstanding (Diluted Average): 2020-2024

Historic Shares Outstanding (Diluted Average) for Puma Biotechnology (PBYI) over the last 5 years, with Dec 2024 value amounting to $49.1 million.

  • Puma Biotechnology's Shares Outstanding (Diluted Average) rose 3.26% to $49.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $49.1 million, marking a year-over-year increase of 3.26%. This contributed to the annual value of $49.1 million for FY2024, which is 3.26% up from last year.
  • Puma Biotechnology's Shares Outstanding (Diluted Average) amounted to $49.1 million in FY2024, which was up 3.26% from $47.6 million recorded in FY2023.
  • In the past 5 years, Puma Biotechnology's Shares Outstanding (Diluted Average) ranged from a high of $49.1 million in FY2024 and a low of $39.6 million during FY2020.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $47.6 million (2023), whereas its average is $47.2 million.
  • Data for Puma Biotechnology's Shares Outstanding (Diluted Average) shows a peak YoY rose of 10.56% (in 2022) over the last 5 years.
  • Yearly analysis of 5 years shows Puma Biotechnology's Shares Outstanding (Diluted Average) stood at $39.6 million in 2020, then rose by 2.69% to $40.6 million in 2021, then grew by 10.56% to $44.9 million in 2022, then climbed by 5.83% to $47.6 million in 2023, then increased by 3.26% to $49.1 million in 2024.